These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17994739)

  • 1. Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.
    Grohe B; O'Young J; Ionescu DA; Lajoie G; Rogers KA; Karttunen M; Goldberg HA; Hunter GK
    J Am Chem Soc; 2007 Dec; 129(48):14946-51. PubMed ID: 17994739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals.
    O'Young J; Chirico S; Al Tarhuni N; Grohe B; Karttunen M; Goldberg HA; Hunter GK
    Cells Tissues Organs; 2009; 189(1-4):51-5. PubMed ID: 18728346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.
    Langdon A; Wignall GR; Rogers K; Sørensen ES; Denstedt J; Grohe B; Goldberg HA; Hunter GK
    Calcif Tissue Int; 2009 Mar; 84(3):240-8. PubMed ID: 19189038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions.
    Grohe B; Taller A; Vincent PL; Tieu LD; Rogers KA; Heiss A; Sørensen ES; Mittler S; Goldberg HA; Hunter GK
    Langmuir; 2009 Oct; 25(19):11635-46. PubMed ID: 19725562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin.
    Hunter GK; Grohe B; Jeffrey S; O'Young J; Sørensen ES; Goldberg HA
    Cells Tissues Organs; 2009; 189(1-4):44-50. PubMed ID: 18703867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.
    Wang L; Qiu SR; Zachowicz W; Guan X; Deyoreo JJ; Nancollas GH; Hoyer JR
    Langmuir; 2006 Aug; 22(17):7279-85. PubMed ID: 16893227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.
    Taller A; Grohe B; Rogers KA; Goldberg HA; Hunter GK
    Biophys J; 2007 Sep; 93(5):1768-77. PubMed ID: 17496021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
    Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
    Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.
    Gleberzon JS; Liao Y; Mittler S; Goldberg HA; Grohe B
    Urolithiasis; 2019 Oct; 47(5):425-440. PubMed ID: 30569197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate modulates calcium oxalate crystal growth by face-specific interactions.
    Grohe B; O'Young J; Langdon A; Karttunen M; Goldberg HA; Hunter GK
    Cells Tissues Organs; 2011; 194(2-4):176-81. PubMed ID: 21555861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free mapping of osteopontin adsorption to calcium oxalate monohydrate crystals by tip-enhanced Raman spectroscopy.
    Kazemi-Zanjani N; Chen H; Goldberg HA; Hunter GK; Grohe B; Lagugné-Labarthet F
    J Am Chem Soc; 2012 Oct; 134(41):17076-82. PubMed ID: 22991940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible inhibition of calcium oxalate monohydrate growth by an osteopontin phosphopeptide.
    Nene SS; Hunter GK; Goldberg HA; Hutter JL
    Langmuir; 2013 May; 29(21):6287-95. PubMed ID: 23611580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flexible polyelectrolyte hypothesis of protein-biomineral interaction.
    Hunter GK; O'Young J; Grohe B; Karttunen M; Goldberg HA
    Langmuir; 2010 Dec; 26(24):18639-46. PubMed ID: 20527831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of calcium oxalate dihydrate growth by phosphorylated osteopontin peptides.
    Chien YC; Mansouri A; Jiang W; Khan SR; Gray JJ; McKee MD
    J Struct Biol; 2018 Nov; 204(2):131-144. PubMed ID: 30016645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
    Hoyer JR; Asplin JR; Otvos L
    Kidney Int; 2001 Jul; 60(1):77-82. PubMed ID: 11422738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hydroxyapatite formation by osteopontin phosphopeptides.
    Pampena DA; Robertson KA; Litvinova O; Lajoie G; Goldberg HA; Hunter GK
    Biochem J; 2004 Mar; 378(Pt 3):1083-7. PubMed ID: 14678013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.
    Chien YC; Masica DL; Gray JJ; Nguyen S; Vali H; McKee MD
    J Biol Chem; 2009 Aug; 284(35):23491-501. PubMed ID: 19581305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorption processes of Gly and Glu amino acids on hydroxyapatite surfaces at the atomic level.
    Pan H; Tao J; Xu X; Tang R
    Langmuir; 2007 Aug; 23(17):8972-81. PubMed ID: 17658861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.